Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Dronabinol on Cannabis Use
NCT01394185Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol in cannabis use disorder (CUD), sponsored by Johns Hopkins University. Primary endpoints: Marijuana Self-administration - Progressive Ratio at 12 days and Marijuana Self-administration - Drug Vs Money Choice at 12 days. Started Feb 2011; status: completed.
02
Drugs
dronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01394185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394185.